I doubt anything but actual #'s on a quarterly gets us to

New Post Public Reply Private Reply Replies (0) Message Board
TheCEO Dead Cat Bouncer #13381

I doubt anything but actual #'s on a quarterly gets us to where we really wanna be.   We get back to that .04-.05 level  and stay for a couple weeks that also would be good but likely do little for us in the long run.

Lurkers and some chart geeks could get us back to .04-.05 like we honestly should be at this point but with all the NSS and the xtra shares the MM's got when people got stopped out in 00's give them the control on paper but in reality the Mitchell's are the key and what is sucking all these delays is giving them ample time to cover in the event of a squeeze. Someone who charts can correct me there if I am wrong but it would appear to me they are gonna have time to review TRRC reports before they ever go to an SEC doc and if that's the case then they can play slow pitch NSS with this all day till they are good and ready to blast it skyward

I would love to see evidence to the contrary... In fact I would argue they can " walk this up "slowly enough to where only the the price is peaked beyond the interest levels of people that dabble in pennies especially with a scandal involved. We can only hope that one MM decides to get greedy and buy up the float to around  the 52 week high and possibly beyond. Do your own math but if we get to 2 or 3 times CFP then what do the MM's do if they see this coming down the pipes ?  .10? .25 ?

Treaty Energy Corporation (TECO) Stock Research Links

TECO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence in Actuarial Science: SCOR Awards 2025

Updated Category News Views 116

SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...

Continue Reading
Gentex Corporation Announces Earnings Release Date for 2024

Updated Category News Views 190

Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...

Continue Reading
Lockton's Strategic Move in Saudi Arabia with New Leadership

Updated Category News Views 197

Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...

Continue Reading
Revolutionizing Defense: AMIAD and Dassault Aviation Unite

Updated Category News Views 158

Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....

Continue Reading
Innovative Trauma Solutions by Globus Medical Enhance Patient Care

Updated Category News Views 133

Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...

Continue Reading